Issue 48, 2016

Multi-component self-assembled anti-tumor nano-vaccines based on MUC1 glycopeptides

Abstract

Novel multi-component self-assembled nano-vaccines containing both Pam3CSK4 and CpG were developed for the first time. These multi-component vaccines could effectively activate the macrophages in vitro and elicit strong antibody immune responses and anti-tumor immune responses in vivo.

Graphical abstract: Multi-component self-assembled anti-tumor nano-vaccines based on MUC1 glycopeptides

Supplementary files

Article information

Article type
Communication
Submitted
07 Mar 2016
Accepted
17 May 2016
First published
17 May 2016

Chem. Commun., 2016,52, 7572-7575

Multi-component self-assembled anti-tumor nano-vaccines based on MUC1 glycopeptides

Z. Y. Sun, P. G. Chen, Y. F. Liu, B. D. Zhang, J. J. Wu, Y. X. Chen, Y. F. Zhao and Y. M. Li, Chem. Commun., 2016, 52, 7572 DOI: 10.1039/C6CC02000C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements